Hormonal Effects on Urticaria and Angioedema Conditions

J Allergy Clin Immunol Pract. 2021 Jun;9(6):2209-2219. doi: 10.1016/j.jaip.2021.04.021. Epub 2021 Apr 22.

Abstract

Women appear to be more frequently affected with urticaria and angioedema. Sex hormones are believed to have an important mechanistic role in regulating pathways involved in these conditions. This effect is likely nonspecific for chronic spontaneous urticaria (CSU) or many forms of angioedema (AE), because many other chronic diseases such as asthma are also affected by sex hormones. The role of sex hormones has been better elucidated for hereditary AE, because they have been shown to have multiple effects including upregulation of FXII, an important activator of the kallikrein pathway. However, their role in the underlying pathogenesis for CSU is less clear. Autoimmunity is clearly linked to CSU, which is more common in women. This suggests that sex hormones could act as adjuvants in activating or upregulating autoimmune pathways. The purpose of this review is to discuss in detail the role of sex hormones in CSU and AE and how a better understanding of the impact hormones has on these conditions might lead to new treatment advancements with better clinical outcomes.

Keywords: Adjuvants; Angioedema; Autoimmunity; Chronic; FXII; Kallikrein; Sex hormones; Urticaria.

Publication types

  • Review

MeSH terms

  • Angioedema* / epidemiology
  • Autoimmunity
  • Chronic Disease
  • Chronic Urticaria*
  • Female
  • Humans
  • Urticaria* / epidemiology